Status:
COMPLETED
A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices
Lead Sponsor:
Procter and Gamble
Conditions:
Gingivitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to evaluate the effect four different dentifrices have on gingivitis after 12 weeks of product use. The secondary objectives are to assess the effect four dentif...
Eligibility Criteria
Inclusion
- Be at least 18 years of age;
- Provide written informed consent prior to participation and be given a signed copy of the informed consent form;
- Be in general good health as determined by the Investigator based on a review of the health history/update for participation in the trial;
- Have at least 16 gradable teeth;
- Have mild to moderate gingivitis with at least 20 bleeding sites;
- Agree to return for scheduled visits and follow the study procedures;
- Agree to refrain from use of any non-study oral hygiene products for the duration of the study;
- Agree to delay any elective dentistry, including dental prophylaxis, until the completion of the study;
- Agree to refrain from any oral hygiene the morning of your visit
- Agree to refrain from eating, drinking (except water), using tobacco, floss, use toothpicks, breath mints, or chew gum after performing your evening brushing.
Exclusion
- Having taken antibiotic, anti-inflammatory, or anti-coagulant medications within 4 weeks of the Baseline Visit;
- Have any oral conditions that could interfere with study compliance and/or examination procedures, such as widespread caries, soft or hard tissue tumor of the oral cavity, or advanced periodontal disease;
- Having had a dental prophylaxis within 2 weeks of plaque sampling visits;
- Removable oral appliances;
- Fixed facial or lingual orthodontic appliances;
- Self-reported pregnancy or lactation;
- Any diseases or condition that might interfere with the safe participation in the study; and
- Inability to undergo study procedures.
Key Trial Info
Start Date :
September 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2023
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT06140784
Start Date
September 2 2023
End Date
December 10 2023
Last Update
March 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHRG
Whittier, California, United States, 90602